Moreover, the quantification of our bioinformatics data also showed that EphB6 is overexpressed by at least two fold in ~76% of T-ALL cases, indicating that the EphB6 receptor may produce a prominent effect on the biological properties of T-ALL cells. Here, EPHB6 is linked to acute lymphoblastic leukemia.